tiprankstipranks
Trending News
More News >
Mayne Pharma Group (AU:MYX)
ASX:MYX

Mayne Pharma Group (MYX) Revenue

Compare
29 Followers

Mayne Pharma Group Revenue

Mayne Pharma Group had a revenue of 213.05M in the quarter ending Dec 31, 2024, with 6.28%. This bring the company's revenue in the last twelve months to 413.53M, Decreased 6.47%. In the fiscal year ending Jun 30, 2024, Mayne Pharma Group had annual revenue of 388.15M with 111.43% growth.
Revenue (ttm)
413.53M
Revenue Growth
52.96%
P/S Ratio
1.47
Revenue/Employee
Employees
Market Cap
$571.97M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024388.15M204.56M+111.43%
Jun 30, 2023183.59M26.44M+16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021400.78M-56.20M-12.30%
Jun 30, 2020456.99M-68.22M-12.99%
Jun 30, 2019525.21M-5.11M-0.96%
Jun 30, 2018530.31M-42.28M-7.38%
Jun 30, 2017572.60M305.32M+114.23%
Jun 30, 2016267.28M126.96M+90.47%
Jun 30, 2015140.32M-1.86M-1.31%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis